Uchrin and CFO Bhavesh Shah to attend and speak at the annual investor conference

NASHVILLE, Tenn. (December 19, 2024) — Monogram Health will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 13-16, 2025. The invitation is a testament to the significant growth of Monogram Health as it enters its sixth year of providing value-based care for patients with polychronic conditions.

CEO and co-founder Mike Uchrin will speak to investors on Monday, January 13, 2025 at 2 p.m. PST.

About Monogram Health 

Monogram Health is a leading value-based multispecialty provider of in-home evidence-based care for patients living with polychronic conditions, notably chronic kidney and end-stage kidney disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with polychronic conditions. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, TPG Capital, as well as other leading strategic and financial investors, Monogram Health has numerous value-based partnerships with leading health plans and risk-bearing providers to care for patients across 36 states and all insurance products. To learn more about Monogram Health, ranked 2024’s No. 3 fastest growing private company in the United States, please visit here. 

###